Buscar en
Revista de Psiquiatría y Salud Mental (English Edition)
Toda la web
Inicio Revista de Psiquiatría y Salud Mental (English Edition)
ISSN: 2173-5050

Incorporated into Spanish Journal of Psychiatry and Mental Health
ISSN 1888-9891

The Spanish Journal of Psychiatry and Mental Health (SJPMH) is the official scientific publication of the Spanish Society of Psychiatry and Mental Health. The journal is oriented to the study of mental illnesses, their pathological processes, and their psychosocial consequences and aims to disseminate scientific advances in all fields related to illness and mental health. It accepts unpublished works on psychiatry and mental health, and its medical and social repercussions. For this reason, space is provided in the journal for research in the biological, clinical and psychosocial fields. Before being accepted, external reviewers (peer-review) evaluate manuscripts.

See more Open Access Option

Indexed in:

Index Medicus/Medline, IBECS, Social Sciences Citation Index Journal Citation Reports/Social Sciences Edition Current Contents/Social and Behavioral Sciences

See more

Follow us:


Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more
Impact factor 2022

CiteScore measures average citations received per document published.

See more
Citescore 2022

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2022

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2022
View more metrics
Vol. 15. Issue 4.
Pages 221-296 (October - December 2022)
Here we go again! Subtyping diagnosis and refining treatments
Javier Vázquez-Bourgon
Rev Psiquiatr Salud Ment. 2022;15:221-2
Full text access
Open Article
Originals articles
Risk factors of deficit and non-deficit schizophrenia: Results from a cross-sectional study
Agnieszka Cyran, Patryk Piotrowski, Jerzy Samochowiec, Tomasz Grąźlewski, Błażej Misiak
Rev Psiquiatr Salud Ment. 2022;15:223-9
Full text access
Open Article
Dried Blood Spot (DBS) as a useful tool to improve clozapine, aripiprazole and paliperidone treatment: From adherence to efficiency
Miguel Bernardo, Gisela Mezquida, Paula Ferré, Bibiana Cabrera, Mercè Torra, Ana Maria Lizana, Mercè Brunet
Rev Psiquiatr Salud Ment. 2022;15:230-7
Full text access
Open Article
Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries
Carlos De las Cuevas, Emilio J. Sanz, Can-Jun Ruan, Jose de Leon
Rev Psiquiatr Salud Ment. 2022;15:238-50
Full text access
Open Article
Clinical symptoms and social functioning in schizophrenia
Maria Jose Escandell, Gemma Prat, Mar Garcia-Franco, Jose Ramón Martín-Martínez, Susana Ochoa, Ingrid Tortades, Sonia Vilamala, Marina Verdaguer-Rodríguez, Emma Casas-Anguera
Rev Psiquiatr Salud Ment. 2022;15:251-8
Full text access
Open Article
Different measures for auditory hallucinations in populations with psychosis. The Validation of the Spanish versions of the Auditory Vocal Hallucination Rating Scale (AVHRS) and the Positive and Useful Voices Inquiry (PUVI)
Esther Lorente-Rovira, Eva Grasa, Susana Ochoa, Iluminada Corripio, Trinidad Peláez, Raquel López-Carrilero, Ángela Gutiérrez-Gea, María Morano-Guillén, ... Julio Sanjuán
Rev Psiquiatr Salud Ment. 2022;15:259-71
Full text access
Open Article
Diagnostic stability in substance-induced psychosis
Lucía Inchausti, Iñigo Gorostiza, Miguel Angel Gonzalez Torres, Rodrigo Oraa
Rev Psiquiatr Salud Ment. 2022;15:272-80
Full text access
Open Article
Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series
Aygün Ertuğrul, A. Elif Anıl Yağcıoğlu, Esen Ağaoğlu, Ahmet Alp Karakaşlı, Sertaç Ak, M. Kâzım Yazıcı, Jose de Leon
Rev Psiquiatr Salud Ment. 2022;15:281-6
Full text access
Open Article
Letter to the editor
Clozapine for the treatment of pediatric encephalopathy associated with nonketotic hyperglycinemia
Sara Jiménez-Fernández, Manuel Gurpegui, Jose de Leon, Luis Gutiérrez-Rojas
Rev Psiquiatr Salud Ment. 2022;15:287-9
Full text access
Open Article
A Covid-19 outbreak in a Spanish long-term psychiatric hospital led to infections in 6 clozapine patients: elevations in their plasma clozapine levels
Manuel Arrojo-Romero, Maria Rosario Codesido-Barcala, Jose de Leon
Rev Psiquiatr Salud Ment. 2022;15:290-2
Full text access
Open Article
A clozapine's uncharted voyage: Five years and a pandemic after the end of mandatory haematological notifications to the Spanish medicines agency
Pilar Andres-Olivera, Concha Turrion, Emilio Fernandez-Egea, Jesus Perez
Rev Psiquiatr Salud Ment. 2022;15:293-4
Full text access
Open Article
Clozapine-induced myocarditis in Russia: Animal studies but no clinical studies
Oleg O. Kirilochev, Carlos De las Cuevas, Jose de Leon
Rev Psiquiatr Salud Ment. 2022;15:294-5
Full text access
Open Article
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos